Access Statistics for Diego Useche

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 0 0 0 0 0 7 40
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital 0 0 0 0 0 2 7 18
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 2 2 13
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 2 22
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 1 2 7 15
Empirical Economic Analysis of Orphan Drug Legislation Impact on Innovation 0 0 0 0 1 4 9 42
Empirical economic analysis of orphan drug legislation impact on innovation 0 0 0 0 1 2 4 420
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 1 4 20 38
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 2 3 15 30
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 1 6 10 22
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 48 1 1 14 103
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 2 7 12
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 0 5 9
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 1 6 34
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 0 16 0 2 8 125
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021 0 0 0 0 1 4 7 15
Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies 0 0 0 0 0 3 8 26
Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies 0 0 0 0 1 2 12 58
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms 0 0 0 7 0 1 7 26
Total Working Papers 0 0 0 71 10 41 157 1,068


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 0 1 45 1 8 34 199
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital 0 0 2 10 2 3 22 73
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 1 24 1 4 25 119
Patenting Behaviour and the Survival of Newly Listed European Software Firms 0 0 0 8 0 5 17 54
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms 0 0 1 9 2 7 15 46
Total Journal Articles 0 0 5 96 6 27 113 491


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 0 14 1 6 16 101
Total Chapters 0 0 0 14 1 6 16 101


Statistics updated 2026-06-04